{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:16:51Z","timestamp":1760548611196,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1124\/dmd.107.018002","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T01:45:56Z","timestamp":1201571156000},"page":"816-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Markers of Electrophilic Stress Caused by Chemically Reactive Metabolites in Human Hepatocytes"],"prefix":"10.1016","volume":"36","author":[{"given":"Hideo","family":"Takakusa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Masumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Mitsuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.107.018002_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.107.018002_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bms.1200220602","article-title":"Mass spectrometry in the analysis of glutathione conjugates","volume":"22","author":"Baillie","year":"1993","journal-title":"Biol Mass Spectrom"},{"key":"10.1124\/dmd.107.018002_bib3","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1073\/pnas.252626999","article-title":"Biliverdin reductase: a major physiologic cytoprotectant","volume":"99","author":"Baranano","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.107.018002_bib4","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1016\/S0002-9343(98)00276-9","article-title":"Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus","volume":"105","author":"Bjorkman","year":"1998","journal-title":"Am J Med"},{"key":"10.1124\/dmd.107.018002_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0041-008X(03)00368-5","article-title":"Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity","volume":"192","author":"Boelsterli","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.107.018002_bib6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0168-8278(03)00095-3","article-title":"Induction of hepatic heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity","volume":"38","author":"Cantoni","year":"2003","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.107.018002_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.104.002402","article-title":"The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity","volume":"33","author":"Cheung","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018002_bib8","first-page":"5617","article-title":"Metabolism of 3-tert-butyl-4-hydroxyanisole by microsomal fractions and isolated rat hepatocytes","volume":"45","author":"Cummings","year":"1985","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.107.018002_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-2952(94)90177-5","article-title":"Studies on the reactivity of acyl glucuronides\u2013VII. Salicyl acyl glucuronide reactivity in vitro and covalent binding of salicylic acid to plasma protein of humans taking aspirin","volume":"47","author":"Dickinson","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.018002_bib10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/tx050217c","article-title":"The role of Keap1 in cellular protective responses","volume":"18","author":"Dinkova-Kostova","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.107.018002_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/tx034170b","article-title":"Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development","volume":"17","author":"Evans","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.107.018002_bib12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/tx0496791","article-title":"Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites","volume":"18","author":"Gan","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.107.018002_bib13","doi-asserted-by":"crossref","first-page":"12112","DOI":"10.1021\/bi010254c","article-title":"Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19","volume":"40","author":"Ha-Duong","year":"2001","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.107.018002_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0024-3205(81)90278-2","article-title":"Acetaminophen-induced hepatotoxicity","volume":"29","author":"Hinson","year":"1981","journal-title":"Life Sci"},{"key":"10.1124\/dmd.107.018002_bib15","doi-asserted-by":"crossref","first-page":"31768","DOI":"10.1074\/jbc.M503346200","article-title":"Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation","volume":"280","author":"Hong","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.018002_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.107.018002_bib17","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1007\/s11095-006-9094-2","article-title":"Induction of heme oxygenase-1 (HO-1) and NAD[P]H: quinone oxidoreductase 1 (NQO1) by a phenolic antioxidant, butylated hydroxyanisole (BHA) and its metabolite, tert-butylhydroquinone (tBHQ) in primary-cultured human and rat hepatocytes","volume":"23","author":"Keum","year":"2006","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.107.018002_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrd1720","article-title":"Elucidating mechanisms of drug-induced toxicity","volume":"4","author":"Liebler","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.107.018002_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/bi00167a022","article-title":"Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid","volume":"33","author":"L\u00f3pez-Garcia","year":"1994","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.107.018002_bib20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0016-5085(97)70054-4","article-title":"Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity","volume":"112","author":"Macfarlane","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.107.018002_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/tx060234h","article-title":"Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans","volume":"20","author":"Masubuchi","year":"2007","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.107.018002_bib22","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/0006-2952(88)90240-7","article-title":"In vivo inhibition of oxidative drug metabolism by, and acute toxicity of, 1-aminobenzotriazole (ABT). A tool for biochemical toxicology","volume":"37","author":"Mico","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.018002_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj20030754","article-title":"Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence","volume":"374","author":"Nioi","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/dmd.107.018002_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/74680","article-title":"Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway","volume":"6","author":"Otterbein","year":"2000","journal-title":"Nat Med"},{"key":"10.1124\/dmd.107.018002_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3565(25)24566-9","article-title":"Metabolism and bioactivation of clozapine by human liver in vitro","volume":"272","author":"Pirmohamed","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.018002_bib26","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.febslet.2006.02.031","article-title":"Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes","volume":"580","author":"Shinkai","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.107.018002_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1345\/aph.1A406","article-title":"Ticlopidine-induced cholestatic hepatitis","volume":"37","author":"Skurnik","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.107.018002_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/dmd.32.1.140","article-title":"An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes","volume":"32","author":"Soars","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.018002_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-2571(02)00038-9","article-title":"Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis","volume":"43","author":"Talalay","year":"2003","journal-title":"Adv Enzyme Regul"},{"key":"10.1124\/dmd.107.018002_bib30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0006-2952(87)90412-6","article-title":"Species differences in the hepatotoxicity of paracetamol are due to differences in the rate of conversion to its cytotoxic metabolite","volume":"36","author":"Tee","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.018002_bib31","first-page":"5196","article-title":"Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray","volume":"62","author":"Thimmulappa","year":"2002","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.107.018002_bib32","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1073\/pnas.0307301101","article-title":"Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers","volume":"101","author":"Wakabayashi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.107.018002_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/10408440590935620","article-title":"Role of metabolism in drug-induced idiosyncratic hepatotoxicity","volume":"35","author":"Walgren","year":"2005","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/dmd.107.018002_bib34","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1074\/jbc.M610790200","article-title":"Nrf2-Keap1 signaling pathway regulates human UGT1A1 expression in vitro and in transgenic UGT1 mice","volume":"282","author":"Yueh","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.018002_bib35","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1128\/MCB.00700-06","article-title":"BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress","volume":"26","author":"Zhang","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.107.018002_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1081\/DMR-200028812","article-title":"Drug bioactivation, covalent binding to target proteins and toxicity relevance","volume":"37","author":"Zhou","year":"2005","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.107.018002_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.1840040223","article-title":"Ticrynafen-associated hepatic injury: analysis of 340 cases","volume":"4","author":"Zimmerman","year":"1984","journal-title":"Hepatology"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562401643X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562401643X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.107.018002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:17:54Z","timestamp":1739895474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562401643X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S009095562401643X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.107.018002","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of Electrophilic Stress Caused by Chemically Reactive Metabolites in Human Hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.107.018002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}